TORONTO, Jan. 31 /CNW/ - Microbix Biosystems Inc. (TSX:MBX) announced
today that it has taken over the production of its urokinase product from
Genpharm Inc. and will directly operate the manufacturing facilities.
The two companies, which have been working together over the past three
years to commercialize the product, have now amended their licensing agreement
to reflect these changes. Microbix will now assume the costs associated with
bringing the drug to market - costs previously funded by Genpharm, an
affiliate of Merck KgaA.
